Jon Ladd

Jon Ladd has extensive work experience in the scientific research field. Jon is currently working at RareCyte, Inc. as a Senior Scientist since July 2022. Prior to this role, they worked as a Scientist at the same company starting from October 2021 until July 2022.

Before joining RareCyte, Inc., Jon worked at Fred Hutch for a significant period. Jon started as a Research Associate at the University of Washington in September 2001 and worked there until March 2008. At Fred Hutch, they held various roles including Staff Scientist from November 2017 to October 2021, Postdoctoral Fellow from January 2015 to November 2017, and Professional Support Specialist from June 2013 to January 2015.

During their time at Fred Hutch, Jon contributed significantly to autoantibody-based diagnostic development for research studies on lung, breast, and colon cancer. Jon developed novel methods for identifying immunogenic proteins and epitopes using mass spectrometry and protein and peptide arrays. Jon also integrated multiple datasets in a systems biology approach to diagnostic development. Additionally, Jon collaborated with research labs, academic institutions, and companies, and provided technical assistance on colleagues' manuscripts and presentations. Jon contributed to several original manuscripts and conference presentations.

Jon Ladd has a strong educational background in Chemical Engineering. Jon started their education journey at Caltech, where they obtained their Bachelor of Science (BS) degree in Chemical Engineering from 1997 to 2001. Jon then continued their studies at the University of Washington, earning their Master of Science (MS) degree in Chemical Engineering from 2001 to 2006. Following this, Jon pursued further specialization in the field by obtaining a Doctor of Philosophy (PhD) degree in Chemical Engineering from the University of Washington, completing their studies from 2006 to 2008. Additionally, Jon holds a Certificate in Biotechnology Project Management from the University of Washington, although the specific acquisition dates are not provided in the information given.